Cargando…
Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer
Neoantigens are optimal tumor-specific targets for T-cell based immunotherapy, especially for patients with “undruggable” mutated driver genes. T-cell immunotherapy can be a “universal” treatment for HLA genotype patients sharing same oncogenic mutations. To identify potential neoantigens for therap...
Autores principales: | Zhou, Jie, Zhao, Wenyi, Wu, Jingcheng, Lu, Jun, Ding, Yongfeng, Wu, Shanshan, Wang, Haiyong, Ding, Ding, Mo, Fan, Zhou, Zhan, Teng, Lisong, Chen, Shuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595338/ https://www.ncbi.nlm.nih.gov/pubmed/31312661 http://dx.doi.org/10.1155/2019/8103142 |
Ejemplares similares
-
TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection
por: Zhou, Zhan, et al.
Publicado: (2017) -
TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis
por: Wu, Jingcheng, et al.
Publicado: (2018) -
DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity
por: Wu, Jingcheng, et al.
Publicado: (2019) -
TSNAD v2.0: A one-stop software solution for tumor-specific neoantigen detection
por: Zhou, Zhan, et al.
Publicado: (2021) -
TSNAdb v2.0: The Updated Version of Tumor-specific Neoantigen Database
por: Wu, Jingcheng, et al.
Publicado: (2023)